On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) announced a settlement agreement with Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) to resolve patent litigation related to Firdapse (amifampridine) 10 mg tablets. This agreement stemmed from a legal dispute initiated by Catalyst and SERB...
